GSK

Key Takeaways GSK’s Specialty Medicines sales rose 14% in the first nine months of 2026, driving its growth…

Jefferies downgraded GSK (LSE:GSK) to Hold from Buy and cut its price target on the U.S.-listed shares to…

GSK came into this Q3 2026 print with the shares under pressure, down about 6% over three months…

Drugs giant GSK has seen shares come under pressure as falling vaccine sales overshadowed a better-than-forecast rise in…

A ‘needle-free’ vaccine against group A streptococcus bacterium (Strep A) is being developed by the Medicines and Healthcare…

Both GSK plc GSK and Moderna MRNA are seeking to drive long-term growth through innovation in vaccines and…

Highlights GSK (LSE:GSK) Healthcare GSK plc (LSE:GSK) 1923.50 GBX +8.500 ↑ 0.444% Last Updated at: 2026-10-27T16:36:00Z publishes its…

GSK (LSE:GSK) has released third quarter figures that present a mixed picture. Sales reached £8,887 million, while net…

GSK Plc (NYSE: GSK) shares fell about 4% in London on Wednesday, at one point dropping 7.3%, after…

GSK plc shares fell 4.78% on Wednesday, October 28, 2026, closing at 1,831.50 pence (GBp) on the London…

Investing.com — GSK PLC shares fell nearly 4% in London trading Wednesday after the drugmaker reported third-quarter results…

]]> Image source: The Motley Fool. DATE Wednesday, Oct. 28, 2026 CALL PARTICIPANTSInvestor Relations – Jeff McLaughlinChief Executive…

GSK vs. Moderna: Which Large-Cap Biotech Stock Offers More Growth? – October 29, 2026